Compounders Research Compare

Actuate Therapeutics Inc(ACTU)

Biotechnology · Fort Worth, TX

$0.81-0.06 (-7.18%)

Delayed quote: Oct 6, 2026, 12:48 PM EDT

About Actuate Therapeutics Inc

Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.

Fort Worth, TX

12 employees

actuatetherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Daniel Schmitt

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T16:50:21.490Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:50:21.490Z.

Quote observation: 2026-10-06T16:48:02.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -0.89
Quote price: 0.8121

FMP input reference: a29a88061d86e64317c53e71c63756e58f7ffa0b55551e6148327154cc786467

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ACTU Earnings Yield Metrics

EARNINGS YIELD

N/A

ACTU Competitors' Earnings Yield

Actuate Therapeutics Inc

Current

Market Cap

$19.43M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Estrella Immunopharma, Inc.

Market Cap

$19.53M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

P3 Health Partners Inc.

Market Cap

$19.67M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NextCure, Inc.

Market Cap

$18.95M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Neuphoria Therapeutics Inc.

Market Cap

$18.65M

Earnings Yield

N/A

TTM Avg

66.69%

3Y Avg

66.69%

5Y Avg

66.69%

Quantum BioPharma Ltd.

Market Cap

$20.89M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cosmos Health Inc.

Market Cap

$17.83M

Earnings Yield

N/A

TTM Avg

2.31%

3Y Avg

2.31%

5Y Avg

2.31%

Lipocine Inc.

Market Cap

$17.23M

Earnings Yield

N/A

TTM Avg

0.00%

3Y Avg

5.85%

5Y Avg

5.85%

Modular Medical, Inc.

Market Cap

$21.76M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Marker Therapeutics, Inc.

Market Cap

$17.01M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Actuate Therapeutics Inc (ACTU)	$19.43M	N/A	N/A	N/A	N/A
Estrella Immunopharma, Inc. (ESLA)vs ›	$19.53M	N/A	N/A	N/A	N/A
P3 Health Partners Inc. (PIII)vs ›	$19.67M	N/A	N/A	N/A	N/A
NextCure, Inc. (NXTC)vs ›	$18.95M	N/A	N/A	N/A	N/A
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.65M	N/A	66.69%	66.69%	66.69%
Quantum BioPharma Ltd. (QNTM)vs ›	$20.89M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$17.83M	N/A	2.31%	2.31%	2.31%
Lipocine Inc. (LPCN)vs ›	$17.23M	N/A	0.00%	5.85%	5.85%
Modular Medical, Inc. (MODD)vs ›	$21.76M	N/A	N/A	N/A	N/A
Marker Therapeutics, Inc. (MRKR)vs ›	$17.01M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics